transitioning from semaglutide to tirzepatide Switching Semaglutide: What to Expect Early Dose Escalation of Tirzepatide
Description
GLP-1/Exendin-4 induces -cell proliferation via the epidermal growth factor receptor
They do not reduce thyroid antibodies, reverse thyroid tissue damage, or modify the autoimmune process
The getting off GLP-1 guide provides a comprehensive overview of the transition process
You're less likely to experience hypoglycemia when you take semaglutide by itself
However, the FDA has tightened oversight and shifted away from enforcement discretion as drug shortages have eased
Incorporating treatment pauses, dosing flexibility, and education to support GLP-1RA therapy persistence
